Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Post by fourbarrelson Apr 16, 2014 12:11pm
219 Views
Post# 22458647

Weststar to conduct site visit at potential target

Weststar to conduct site visit at potential targetThey are clearly being cautious with what news they release. Read between the lines. Weststar to conduct site visit at potential target 2014-04-16 09:25 ET - News Release Mr. Will Rascan reports WESTSTAR ADVANCES DUE DILIGENCE WITH SITE VISIT Weststar Resources Corp. wishes to provide an update to its shareholders. Weststar's management will be conducting a site visit this week as part of its continuing due diligence of a B.C. private company (PrivCo); see the news release dated April 7, 2014. PrivCo is located within a secured, fully serviced, industrial-zoned 18,000-square-foot facility in the Lower Mainland of British Columbia. Furthermore, management has requested an asset valuation report from PrivCo to better evaluate the company itself, as well as an in-depth analysis of the business opportunities within the Canadian medicinal marijuana sector. Will Rascan stated, "Due to the complexities and detailed information obtained, Weststar is ensuring shareholders that it is continuing a thorough review of all pertinent aspects of the potential opportunities with PrivCo's seed-to-sale business." No agreement in principle has been entered into with any parties, and there is no assurance that the company will acquire any medicinal-marijuana-related assets. Weststar cautions investors to carefully consider the risk of investing in the shares of the company prior to the announcement of such a transaction. We seek Safe Harbor.
Bullboard Posts